Therefore, inhibition of C1QBP in tumor cells and promotion of C1QBP in immune cells would beneficially adjust the competitive balance between tumor and immune cells, providing a very reasonable therapeutic opportunity by finding a way to correctly fine-tune mitochondrial-based metabolic flexibility (Figure 2). This evidence concerns the gene C1QBP and neoplasm.